Stonepine Capital Management, LLC Angion Biomedica Corp. Transaction History

Stonepine Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.35 - $9.95 $658,430 - $2.79 Million	-280,183 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.31 - $13.25 $533,900 - $759,847	57,347 Added 25.74%	280,183 $2.74 Million
Q2 2021 Aug 16, 2021	BUY	$13.02 - $17.83 $1.14 Million - $1.57 Million	87,852 Added 65.08%	222,836 $2.9 Million
Q1 2021 May 14, 2021	BUY	$15.01 - $25.74 $2.03 Million - $3.47 Million	134,984 New	134,984 $2.44 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.